hydralazine has been researched along with deoxycytidine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dayton, PG; Israili, ZH | 1 |
Chuang, JC; Jones, PA; Kwan, JM; Li, TW; Liang, G; Yang, AS; Yoo, CB | 1 |
Candelaria, M; Chavez-Blanco, A; de la Cruz-Hernandez, E; Diaz-Chavez, J; Dominguez, G; Duenas-Gonzalez, A; Gonzalez-Fierro, A; Perez-Cardenas, E; Soto-Reyes, E; Taja-Chayeb, L; Trejo-Becerril, C; Trujillo, JE | 1 |
3 other study(ies) available for hydralazine and deoxycytidine
Article | Year |
---|---|
Hydralazine reactions.
Topics: Deoxycytidine; Humans; Hydralazine; Thymidine | 1981 |
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; Deoxycytidine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Silencing; HT29 Cells; Humans; Hydralazine; Male; Procainamide; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.
Topics: Antimetabolites, Antineoplastic; Blotting, Western; Cell Culture Techniques; Cell Line, Tumor; Chromatin Immunoprecipitation; Deoxycytidine; DNA Primers; Drug Resistance, Neoplasm; Epigenesis, Genetic; Equilibrative Nucleoside Transporter 1; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens; Histone Deacetylases; Histone-Lysine N-Methyltransferase; Humans; Hydralazine; Reverse Transcriptase Polymerase Chain Reaction; Uterine Cervical Neoplasms | 2012 |